We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+523.41%
AUM
$447B
AUM Growth
+$29B
Cap. Flow
-$5.27B
Cap. Flow %
-1.18%
Top 10 Hldgs %
16.98%
Holding
4,386
New
134
Increased
1,479
Reduced
2,453
Closed
124

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$431M
2
TFC icon
Truist Financial
TFC
+$346M
3
BABA icon
Alibaba
BABA
+$238M
4
NOW icon
ServiceNow
NOW
+$228M
5
CTVA icon
Corteva
CTVA
+$156M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$875M
2
GUNR icon
FlexShares Global Upstream Natural Resources Index Fund
GUNR
+$395M
3
STI
SunTrust Banks, Inc.
STI
+$340M
4
ORCL icon
Oracle
ORCL
+$197M
5
AAPL icon
Apple
AAPL
+$171M

Sector Composition

Rank Sector Weight
1 Technology 18.13%
2 Financials 14.48%
3 Healthcare 12.77%
4 Consumer Discretionary 9.62%
5 Industrials 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MARK
4126
DELISTED
Remark Holdings, Inc.
MARK
$27K ﹤0.01%
5,381
-343
-6% -$2.36K
SURF
4127
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$27K ﹤0.01%
14,610
– –
GMO
4128
DELISTED
General Moly, Inc.
GMO
$27K ﹤0.01%
118,943
– –
BLPH
4129
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$27K ﹤0.01%
5,085
– –
NAVB
4130
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$27K ﹤0.01%
21,951
+9,717
+79% +$8.39K
UAMY icon
4131
United States Antimony
UAMY
$988M
$26K ﹤0.01%
68,588
+214
+0.3% +$98
VCSH icon
4132
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.9B
$26K ﹤0.01%
31,585
+9,204
+41% +$746K
WHLR
4133
Wheeler Real Estate Investment Trust
WHLR
$390K
– –
0
– –
ZDGE icon
4134
Zedge
ZDGE
$38.4M
$26K ﹤0.01%
16,924
-38
-0.2% -$65
SEEL
4135
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$26K ﹤0.01%
5
-2
-29% -$7.67K
SQBG
4136
DELISTED
Sequential Brands Group, Inc.
SQBG
$26K ﹤0.01%
1,870
– –
SPHS
4137
DELISTED
Sophiris Bio, Inc.
SPHS
$26K ﹤0.01%
70,600
– –
ALT icon
4138
Altimmune
ALT
$593M
$25K ﹤0.01%
12,993
-2,863
-18% -$5.29K
KUST
4139
Kustom Entertainment Inc
KUST
$683K
– –
0
– –
CYPH
4140
Cypherpunk Technologies Inc
CYPH
$72.4M
$25K ﹤0.01%
2,276
– –
ZSAN
4141
DELISTED
Zosano Pharma Corporation
ZSAN
$25K ﹤0.01%
464
– –
ADXS
4142
DELISTED
Advaxis Inc
ADXS
$25K ﹤0.01%
+29,378
New +$13.4K
KOSS icon
4143
Koss Corp
KOSS
$35.7M
$24K ﹤0.01%
15,395
-146
-0.9% -$249
GRDX
4144
GridAI Technologies Corp
GRDX
$21.1M
– –
0
– –
OGEN icon
4145
Oragenics
OGEN
$2.47M
$23K ﹤0.01%
25
– –
OSS icon
4146
One Stop Systems
OSS
$315M
$23K ﹤0.01%
11,144
– –
QRHC icon
4147
Quest Resource Holding
QRHC
$31.2M
$23K ﹤0.01%
10,427
– –
SDPI
4148
DELISTED
Superior Drilling Products Inc.
SDPI
$23K ﹤0.01%
28,526
– –
NMTR
4149
DELISTED
9 Meters Biopharma
NMTR
$23K ﹤0.01%
2,062
+686
+50% +$11.4K
VRDN icon
4150
Viridian Therapeutics
VRDN
$2.61B
$22K ﹤0.01%
3,058
– –
164 165
166
167 168

Similar funds

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
  • Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
  • Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
  • Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
  • Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
  • Northern Trust opened 134 new positions and closed 124 in Q4 2019.
  • Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.

Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.